모세관 전기 영동 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Capillary Electrophoresis Market was valued at USD 367.2 million in 2024 and is estimated to grow at a CAGR of 5.6% to reach USD 633.1 million by 2034. As the healthcare industry shifts toward more accurate, personalized, and data-driven treatment approaches, the demand for efficient analytical tools like capillary electrophoresis is on the rise. This technology is gaining ground due to its high precision in separating small molecules or ions based on size and charge, which makes it exceptionally effective for genetic analysis, disease diagnostics, and pharmaceutical research. With growing applications in genomics, proteomics, and forensic science, capillary electrophoresis continues to attract attention across academic, clinical, and industrial research landscapes.

Researchers and clinicians are increasingly leaning on this method to detect genetic mutations, monitor pathogens, and analyze complex biological mixtures, which is helping them formulate better-targeted therapies and improve overall patient outcomes. The market is also witnessing strong momentum due to rising investments in R&D, regulatory support for advanced diagnostic methods, and the rapid integration of this technology into next-generation sequencing workflows. As global demand for precision medicine grows, capillary electrophoresis is emerging as an indispensable part of the molecular diagnostics toolkit.

The market is segmented into instruments, consumables, and software. Among these, consumables held a significant share, generating USD 216.5 million in 2024, and are expected to expand at a CAGR of 5.4% through 2034. Consumables such as capillaries and specialized reagents are critical to maintaining the integrity and performance of the technique. With laboratories relying heavily on consistent, high-quality consumables to ensure accurate results, this segment continues to see steady growth driven by routine demand.

Based on type, the capillary gel electrophoresis (CGE) segment accounted for a 45.7% market share in 2024. CGE is widely used to separate large biomolecules like DNA, RNA, and proteins, making it a go-to technique for genetic sequencing, mutation analysis, and proteomics. Its ability to deliver highly accurate results makes it indispensable for research and diagnostic applications that require the separation of complex biological compounds.

The U.S. Capillary Electrophoresis Market is expanding rapidly, driven by rising demand for early disease detection, especially in oncology. The technique enables high-resolution analysis of genetic markers linked to cancer, facilitating the development of personalized treatment plans. Ongoing innovations from leading research institutions are enhancing the technique's precision, particularly in biomarker identification.

Leading players, including Thermo Fisher Scientific, QIAGEN, Bio-Techne, and Agilent Technologies, are focused on advancing their product portfolios. These companies are enhancing instrument sensitivity, improving consumable performance, and pursuing collaborations to introduce integrated systems that align with the growing need for personalized healthcare solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidences of infectious disease
    • 3.2.1.2 Expanding applications in pharmaceutical and biotech industries
    • 3.2.1.3 Rising demand for genetic and molecular research
    • 3.2.1.4 Technological advancement in capillary electrophoresis
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High initial investment and maintenance costs
    • 3.2.2.2 Limited availability of highly trained professionals in emerging countries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
  • 5.2.1 Automatic capillary electrophoresis systems
  • 5.2.2 Semi-automatic capillary electrophoresis systems
• 5.3 Consumables
• 5.4 Software

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Capillary zone electrophoresis (CZE)
• 6.3 Micellar electrokinetic capillary chromatography (MEKC)
• 6.4 Capillary electrochromatography (CEC)
• 6.5 Capillary isoelectric focusing (CIEF)
• 6.6 Capillary isotachophoresis (CITP)
• 6.7 Capillary gel electrophoresis (CGE)

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Nucleic acid analysis
• 7.3 Protein analysis
• 7.4 Genomic DNA
• 7.5 Plasmid DNA
• 7.6 Fragment analysis
• 7.7 RNA/mRNA analysis
• 7.8 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical and biotechnology companies
• 8.3 Academic and research organizations
• 8.4 Clinical laboratories
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Agilent Technologies
• 10.2 Bio-Rad Laboratories
• 10.3 Bio-Techne
• 10.4 Danaher Corporation
• 10.5 Helena Laboratories Corporation
• 10.6 Lumex Instruments
• 10.7 Merck
• 10.8 Prince Technologies
• 10.9 QIAGEN
• 10.10 Thermo Fisher Scientific